88 FR 16 pg. 4826 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—DD23-001, Birth Defects Study To Evaluate Pregnancy ExposureS (BD-STEPS); Amended Notice of Closed Meeting
Type: NOTICEVolume: 88Number: 16Page: 4826
Page: 4826FR document: [FR Doc. 2023-01435 Filed 1-24-23; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-DD23-001, Birth Defects Study To Evaluate Pregnancy ExposureS (BD-STEPS); Amended Notice of Closed Meeting
Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-DD23-001, Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS); March 28-29, 2023, 10 a.m.-5 p.m., EDT, Teleconference, in the original FRN. The meeting was published in the Federal Register on December 23, 2023, Volume 87, Number 246, page 78968.
The meeting is being amended to change the meeting date and time and should read as follows:
Date: March 29, 2023.
Time: 10 a.m.-6 p.m., EDT.
The meeting is closed to the public.
FOR FURTHER INFORMATION CONTACT:
Catherine Barrett, Ph.D., Scientific Review Officer, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway, Mailstop S107-3, Atlanta, Georgia 30341-3717; Telephone: (404) 718-7664; Email: CBarrett@cdc.gov.
The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-01435 Filed 1-24-23; 8:45 am]
BILLING CODE 4163-18-P